Details for New Drug Application (NDA): 077869
✉ Email this page to a colleague
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 077869
Tradename: | ZONISAMIDE |
Applicant: | Invagen Pharms |
Ingredient: | zonisamide |
Patents: | 0 |
Pharmacology for NDA: 077869
Mechanism of Action | Carbonic Anhydrase Inhibitors P-Glycoprotein Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 077869
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077869 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8266 | 0615-8266-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8266-39) |
ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077869 | ANDA | AvPAK | 50268-816 | 50268-816-15 | 50 BLISTER PACK in 1 BOX (50268-816-15) / 1 CAPSULE in 1 BLISTER PACK (50268-816-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | May 31, 2006 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | May 31, 2006 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | May 31, 2006 | TE: | AB | RLD: | No |
Complete Access Available with Subscription